| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J. Biol. Chem., Vol. 279, Issue 32, 33306-33314, August 6, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Prassis sigma-tau Research Institute, Settimo Milanese, 20019 Milan, Italy and the ¶Division of Nephrology, Dialysis and Hypertension, Vita e Salute University, San Raffaele Hospital, 20132 Milan, Italy
Received for publication, February 27, 2004 , and in revised form, May 20, 2004.
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONEXPERIMENTAL PROCEDURESRESULTSDISCUSSIONREFERENCES |
|---|
1, 
1, 
a Na-K ATPase subunits together with Src and EGFr in isolated renal caveolae membranes and activation of ERK1/2. In caveolae, direct Na-K ATPase/Src interactions can be demonstrated by co-immunoprecipitation. The interaction is amplified by ouabain, at a high affinity binding site, detectable in caveolae but not in total rat renal membranes. The high affinity site for ouabain is associated with Src-dependent tyrosine phosphorylation of rat 1 Na-K ATPase. The antihypertensive compound, PST 2238, antagonized all ouabain-induced effects at 10 µg/kg/day in vivo or 10-10-10-8 M in vitro. These findings provide a molecular mechanism for the in vivo pro-hypertrophic and hypertensinogenic activity of ouabain, or by analogy those of EO in humans. They also explain the pharmacological basis for PST 2238 treatment. |
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONEXPERIMENTAL PROCEDURESRESULTSDISCUSSIONREFERENCES |
|---|
1 isoform of Na-K ATPase, ouabain inhibits a component of active 86Rb uptake with a high affinity (9).
The endogenous ouabain (EO), or a close related isomer (10), circulates in mammalians at concentrations in the subnanomolar range (11-13) and has been implicated in the development of hypertension (12, 14), alterations of renal sodium reabsorption and cardiac and renal complications (12-16). Furthermore, the hypertensinogenic activity of low ouabain concentrations might also be ascribed to a specific vasotonic effect as demonstrated in rodent vessels (17, 18).
However, a direct demonstration that the ouabain/Na-K ATPase signaling effects are also relevant to the cardiovascular effects of EO in vivo is still lacking and the following questions have to be elucidated, at least in the experimental rat model. 1) Do in vivo variations of rat plasma ouabain, within the subnanomolar concentrations range, produce cardiac and renal hypertrophy and activate an ERK-dependent transduction pathway mediated by the interaction of 1 Na-K ATPase with signaling proteins in defined membrane microdomains, such as caveolae? 2) Is it possible to reproduce in vitro the in vivo signaling effects by demonstrating that subnanomolar concentrations of ouabain trigger interactions among Na-K ATPase, Src, and EGFr?
The new ouabain-antagonist, PST 2238 (19, 20) is an important tool in this study. We have demonstrated previously that PST 2238 selectively binds to Na-K ATPase and not to other general or hormonal receptors (20) involved in blood pressure regulation or hormonal steroid control, antagonizes the pressor effect of subnanomolar ouabain concentrations and normalizes the ouabain-induced renal Na-K ATPase up-regulation in rats and renal cells (20). This pharmacological tool has now been used to substantiate the specificity of the ouabain/Na-K ATPase interaction in caveolae and to provide evidence on its molecular mechanism of action.
|
EXPERIMENTAL PROCEDURES |
|---|
|
TOPABSTRACTINTRODUCTIONEXPERIMENTAL PROCEDURESRESULTSDISCUSSIONREFERENCES |
|---|
-(3-furyl)-5-androstan-3,14,17-triol) (Fig. 1), a digitoxigenin derivate (Sigma-tau, Pomezia, Rome, Italy) whose synthesis and pharmacological characteristics are described elsewhere (19, 20).
|
-32P]ATP (0.5-3 Ci/mmol, 3000 Ci/mmol) and [3H]ouabain (15 Ci/mmol) (Amersham Biosciences). The following antibodies were used: anti-caveolin (BD); anti-clathrin (Cymbus, CBL); anti-1 and anti-1 Na-K ATPase (UBI); anti-2 Na-K ATPase (McB2, from K. Sweadner); anti-3 Na-K ATPase (Biomol); anti-Src (Santa Cruz Biotechnology); anti-Src, GD11 clone (UBI); Src-Tyr418 and Src-Tyr529 (BIOSOURCE); ERK and dual-phosphorylated (Thr202/Tyr204) ERK (Cell Signaling); anti-a/b Na-K ATPase (C33), anti-a, and anti-b Na-K ATPase (from S. Karlish) and anti-EGFr (from P. Di Fiore); anti-phosphotyrosine PY99 (Santa Cruz Biotechnology); and recombinant active Src and Src-substrate peptide (UBI); Src inhibitor PP2 (Calbiochem). In Vivo Studies—All procedures were in accordance with Institutional Guidelines for animal care. Three-week-old male Sprague-Dawley rats (Harlan, IN), weighing 100-110 g, were subcutaneously implanted with osmotic mini-pumps, releasing either 15 µg/kg/day of ouabain (OS rats, n = 20) for 18 weeks or sterile saline (CS rats, n = 10) (20). At the 6th week of ouabain infusion, OS rats were randomly assigned to two groups (n = 10 each): the first (OS-treated) received PST 2238 orally at 10 µg/kg/day, suspended in 0.5% w/v Methocel, and the second group (OS controls) only vehicle. Systolic blood pressure (SBP) and heart rate (HR) were measured weekly in conscious rats by tail-cuff plethysmography (BP recorder, U. Basile, Italy). At the end of the experiment, rats were sacrificed by cervical dislocation. Blood was collected and plasma separated by centrifugation. Heart and kidney were excised and weights normalized for tibia length.
Plasma and Tissue Ouabain Determination—Ouabain was extracted from plasma, left ventricle free-wall (LVFW), and kidney and measured by a radioimmunoassay, as described (11).
Rat Kidney Caveolae Preparation and ERK1/2 Measurement—Rat kidneys were homogenized in: (mM) 200 sodium carbonate, pH 11, 2 sodium orthovanadate, 100 mg/liter Pefabloc and centrifuged at 100,000 x g for 30 min. The cytosol was utilized for total and dual-phosphorylated (Thr202/Tyr204) ERK1/2 quantification by Western blotting. The pellet was used for caveolae isolation following a detergent-free method and fractionation on a 5-45% sucrose gradient (21). Nineteen fractions were automatically collected and protein content determined (Pierce). The distribution along the gradient of the plasma membrane, Golgi, and endoplasmic reticulum was established by measuring alkaline phosphatase, -mannosidase II, and -glucosidase II activity, respectively (22).
Na-K ATPase Activity Assay—Na-K ATPase activity was measured by [32P]ATP hydrolysis method (23) in sucrose fractions washed in: (mM) 250 sucrose, 30 histidine, pH 7.2, and in purified Na-K ATPase obtained from rat kidney medulla, as described (24).
To investigate the effect of Src on Na-K ATPase activity, recombinant Src kinase, or its medium, was incubated with purified rat renal 1 Na-K ATPase (protein ratio 1:50) for 30 min at 30 °C in a buffer containing: (mM) 150 NaCl, 3 MgCl2, 3 ATP, and 70 Hepes-Tris, pH 7.4, supplemented with 3 mM MnCl2. The effect of increasing concentrations of ouabain was evaluated. Na-K ATPase activity was measured as above (23).
[3H[Ouabain Binding and Scatchard Analysis—Washed renal caveolae were incubated at 37 °C for 1 h with increasing concentrations of [3H]ouabain in a medium containing 3 mM MgCl2, 5 mM phosphoric acid, pH 7.4. Concentrations of labeled ouabain higher than 10-6 M were obtained by isotopic dilution with cold ouabain. Nonspecific binding was determined in the presence of 20 mM ouabain. The separation of bound from free-labeled ouabain was achieved by a rapid filtration method on Whatman GF/F filters, which were washed three times and counted for radioactivity.
Co-immunoprecipitation Experiments—Washed renal caveolae were incubated for 30 min at 30 °C in the absence or presence of ouabain in: (mM) 10 Tris, 10 MgCl2, 5 MnCl2, 0.25 EGTA, 0.025 sodium orthovanadate, 80 NaCl, 2 ATP, 100 mg/liter Pefabloc, pH 7.4. When specified, PST 2238 or amlodipine were added. The samples were incubated with 0.2% CHAPS for 15 min at 4 °C and then with anti-Src antibody (GD11 clone), conjugated to protein G-Sepharose beads (Sigma) for 4 h. A sample of caveolae, incubated with a non-immune IgG (Sigma), instead of the anti-Src antibody, was used as control. The immunocomplexes were precipitated, washed three times with the immunoprecipitation buffer containing CHAPS, and boiled with Laemmli sample buffer. Supernatants were subjected to SDS-polyacrylamide gel electrophoresis and Western blotting and probed with specific antibodies.
In Vitro Src Phosphorylation of Na-K ATPase—Na-K ATPase phosphorylation by Src was measured in vitro by 32Pi incorporation method (A) and Western blotting with an anti-phosphotyrosine antibody (PY99) (B). Method A: 3 µg of purified rat renal 1 Na-K ATPase were incubated for 10 min at 30 °C in the absence, or presence of 50 ng of recombinant Src protein kinase in a medium containing: (mM) 10 Tris, pH 7.4, 10 MgCl2, 5 MnCl2, 0.25 EGTA, 0.025 sodium orthovanadate, 80 NaCl, 0.1 ATP, and [32P]ATP (1500 cpm/nmol, specific activity 3000 Ci/mmol). The reaction was stopped by addition of Laemmli sample buffer. The samples were then subjected to SDS-polyacrylamide gel electrophoresis, followed by autoradiography. Method B: Na-K ATPase was incubated with Src kinase, as in method A, in a medium supplemented with 2 mM cold ATP in the absence of [32P]ATP. When specified, before the addition of Na-K ATPase, Src kinase was preincubated with its specific inhibitor, PP2 (5 µM), for 30 min at 4 °C or with a specific Src substrate peptide (500 µM), instead of Na-K ATPase. The effect of 10-10-10-8 M ouabain was tested. The reaction was stopped by addition of Laemmli sample buffer. The samples were subjected to SDS-polyacrylamide gel electrophoresis and Western blotting and probed with specific antibodies to verify the tyrosine phosphorylation of Na-K ATPase (PY99) and Src kinase (Src-Tyr418 and Src-Tyr529).
Western Blotting—Samples were separated by SDS-polyacrylamide gel electrophoresis (7-15% acrylamide in glycine or 12% acrylamide in Tricine gels), blotted and overnight incubated at 4 °C with specific primary antibodies, followed by 1 h incubation with horseradish peroxidase-linked secondary antibody and chemiluminescent reaction (Lumi-Glo reagent, Cell Signaling). Autoradiography was performed, bands were scanned with Bio-Rad GS710 densitometer and quantified by Bio-Rad Quantity One Software. Blots were stripped (Re-Blot plus, Chemicon) and reprobed no more than three times.
Statistical Analysis—Data are reported as mean ± S.E. The difference among groups was analyzed by one-way analysis of variance, followed by Fisher's least squares difference test. p < 0.05 was considered statistically significant. Ouabain dose-response curves and Scatchard plots were analyzed by a nonlinear regression program (GraphPad Prism Software, version 3).
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONEXPERIMENTAL PROCEDURESRESULTSDISCUSSIONREFERENCES |
|---|
|
These data indicate that in vivo variations of ouabain concentrations within the subnanomolar range, similar to those reported for EO in humans, cause organ hypertrophy in rats besides raising blood pressure. The demonstration that amlodipine prevents the ouabain-induced increase of blood pressure without affecting in vivo organ hypertrophy excludes that the prohypertrophic effect of ouabain might be secondary to pressure overload.
Expression of Na-K ATPase and Signaling Molecules in Total Renal Membranes and Caveolae—Preliminary Western blotting analysis of Na-K ATPase, EGFr, and Src in total renal membranes (MT) from CS, OS, and PST 2238-treated OS rats (n = 6) indicated that ouabain infusion significantly increased 1 Na-K ATPase subunit (+16%, p < 0.01) paralleled by an increase, although not statistically significant, of the 1 Na-K ATPase subunit (+11%), EGFr (+14%), and Src (+10%) compared with CS. In the PST 2238-treated OS rats all these differences disappeared.
In order to investigate the possibility that the ouabain-induced effects on the protein expression observed in MT are amplified in restricted membrane subdomains, we isolated and characterized renal caveolae from CS, OS, PST 2238-treated OS rats. A typical protein distribution of the renal membranes fractionated on the sucrose density gradient is depicted in Fig. 3. The low density fractions (Fig. 3A, fractions 5-8, containing 5% of the total proteins) contained the specific markers of caveolae (25, 26), such as caveolin 1, EGFr, and Src, which were enriched 30-, 40-, and 22-fold, respectively, compared with renal MT (Fig. 3B) and were therefore referred to as caveolae. Interestingly, caveolae were enriched 4-fold in 1, 1, and the a splice variant of the Na-K ATPase subunits as compared with MT (Fig. 3B). The b variant was not detected. The absence of clathrin, the marker for coated pits (Fig. 3B), excludes contamination by these vesicles. Mannosidase and glucosidase activities were also absent (not shown) in caveolae, thus excluding possible Golgi or endoplasmic reticulum membrane contaminations.
|
a and b splice variants of Na-K ATPase (not shown), were referred to as plasma membrane. Effect of Ouabain on the Expression of Na-K ATPase and Signaling Molecules in Renal Caveolae—A representative immunoblotting of the Na-K ATPase subunits and signaling molecules in caveolae isolated from one CS, OS, and PST 2238-treated OS rat is shown in Fig. 4A. The densitometric analysis performed on caveolae from six rats for each group, expressed as percent increase over CS, is shown in Fig. 4B and C. Caveolin 1 content was similar in the three groups of rats. Ouabain significantly increased the recruitment of EGFr, Src, and phosphorylated Src at Tyr418, the Src active form (26) (Fig. 4B) in the OS group. The phospho/non-phospho Src ratio resulted 45% increased in OS over CS control rats (p < 0.01). Moreover, the content of the Na-K ATPase subunits was significantly increased in OS caveolae as compared with CS controls (Fig. 4C).
|
and subunits (Fig. 4C). Effect of Ouabain on ERK1/2 Activation—We further investigated whether the effect of ouabain infusion on Na-K ATPase, Src, EGFr expression into caveolae might result in the activation of the ERK pathway and whether PST 2238 might reverse this effect. Fig. 5 shows the results obtained by probing kidney extracts from CS, OS, and PST 2238-treated OS rats (n = 6) with anti-total and anti-dual phosphorylated ERK1/2 antibodies. Ouabain caused a significant increase of total p44 (ERK1) and p42 (ERK2) levels as compared with CS controls and PST 2238 reverted this effect (Fig. 5A). Interestingly, ouabain induced an increase of dual-phosphorylated forms of ERK1/2 versus CS controls that was abolished by PST 2238 (Fig. 5B).
|
Na-K ATPase Activity and Ouabain Affinity in Rat Renal Caveolae—Since previous work indicated that ouabain signaling depends upon its interaction with Na-K ATPase (5, 6), we investigated whether rat 1 Na-K ATPase localized in caveolae retains its catalytic activity and affinity for ouabain. This latter aspect is crucial when assessing the physiological relevance of nanomolar concentrations of ouabain in rat kidney where only the ouabain-resistant 1 isoform has been detected (27).
The enzymatic activity of renal MT and caveolae, obtained from CS rats (n = 4), was respectively 3.6 and 2.4 µmol of Pi/min/mg protein as compared with 6 µmol of Pi/min/mg protein for a partially purified rat renal 1 Na-K ATPase. The inhibitory ouabain dose-response curves measured in rat renal caveolae showed the presence of a predominant component with low affinity for ouabain (IC50 = 1.3 x 10-4 M), close to that of the purified renal Na-K ATPase (Fig. 6A) and MT (not shown). However, only in caveolae, the ouabain dose-response curve was best fitted according to a two-binding site model (nonlinear regression program, GraphPad Prism Software: one-binding site model, R2 = 0.89; two-binding site model, R2 = 0.99, p < 0.0001, F = 84.09) showing a second minor component (around 25%) of Na-K ATPase having a higher affinity for ouabain (IC50 = 1.2 x 10-7 M) (Fig. 6A, inset) and activity of 0.6 µmol of Pi/min/mg protein.
|
In order to test whether the caveolar high affinity component of Na-K ATPase might be indicative of the presence of the 2 or 3 Na-K ATPase isoforms, caveolae were probed with the anti-2 and anti-3 Na-K ATPase specific antibodies and analyzed by immunoblotting (Fig. 6C) in comparison to renal MT. Neither 2 nor 3 isoforms were detected in caveolae or MT while, as expected, a positive immunoreactivity against the two isoforms was observed in rat brain Na-K ATPase (enzymatic activity = 4 µmol of Pi/min/mg of protein). These data (Fig. 6, A and B) indicate that a pool of Na-K ATPase having high affinity for ouabain is present in rat kidney caveolae.
Co-immunoprecipitation of 1 Na-K ATPase and Src in Rat Renal Caveolae: Effect of Ouabain and PST 2238 —To further investigate the role of subnanomolar ouabain concentrations in determining the interaction between Na-K ATPase and signaling molecules in caveolae, co-immunoprecipitation experiments between Na-K ATPase and Src were performed in the presence of various ouabain concentrations and with or without the addition of PST 2238 or Amlodipine, a Ca2+ antagonist that should not interfere with the ouabain binding to Na-K ATPase. In multiple independent experiments performed with an anti-Src antibody in CS renal caveolae (n = 6), 1 Na-K ATPase co-immunoprecipitated with Src (control sample, Fig. 7A). In the presence of ouabain (10-12 to 10-5 M), the amount of 1 Na-K ATPase co-immunoprecipitated with Src increased progressively to a maximum as the ouabain concentrations were increased from 10-12 to 10-10 or 10-9 M and decreased further to 10-5 M ouabain (Fig. 7A). The result is a bell-shaped curve of the efficiency of the 1 Na-K ATPase co-immunoprecipitation versus ouabain concentrations. The amount of immunoprecipitated Src was not affected by the presence of ouabain. Non-immune IgG did not significantly co-immunoprecipitate Na-K ATPase with Src (not shown). The effect of PST 2238 on the ouabain-induced Na-K ATPase/Src complex formation was then investigated: in the absence of ouabain, 10-8 M PST 2238 alone resulted inactive (Fig. 7B); 10-8 M PST 2238, simultaneously added to ouabain (10-8 or 10-10 M), reduced the 1 Na-K ATPase/Src ratio at both ouabain concentrations (Fig. 7B); 10-10 M PST 2238 was still effective in reducing the Na-K ATPase/Src ratio induced by 10-10 M ouabain, but not by 10-8 M ouabain (Fig. 7B). Amlodipine, at 10-8 M, did not interfere with the formation of the immunoprecipitated complex induced either alone or in the presence of 10-8 or 10-10 M ouabain (Fig. 7B).
|
1 Na-K ATPase (+28%), Src (+33%), and EGFr (+19%). PST 2238, at 10-8 or 10-10 M, but not amlodipine at 10-8 M, antagonized the ouabain-induced increase in tyrosine phosphorylation of the immunoprecipitated proteins (-20%). In the co-immunoprecipitation experiments, ouabain appeared to be effective at concentrations lower than those for the high affinity ouabain binding site obtained in the Scatchard analysis and Na-K ATPase inhibitory activity. A possible explanation for these apparent discrepant values may reside both in the low specific activity of [3H]ouabain (15 Ci/mmol), that does not allow to measure an appreciable binding below 4 x 10-9 M of [3H]ouabain, and in the presence of 10 mM KCl, needed for the enzymatic activity measurement, that may affect ouabain binding either to the high or low affinity site (28).
In conclusion, these findings further support the evidence that subnanomolar concentrations of ouabain bind to the rat renal 1 Na-K ATPase in the caveolar membranes and favor the interaction of Na-K ATPase with signaling molecules in this membrane subdomain. PST 2238 is able to antagonize this ouabain effect presumably by antagonizing its binding to the high-affinity component of 1 Na-K ATPase localized in this district.
Src Phosphorylation of Na-K ATPase in an in Vitro Assay: Effect of Ouabain—In order to test whether the binding of low concentrations of ouabain to rat 1 Na-K ATPase may be favored by a Src-induced phosphorylation of the enzyme, purified rat renal 1 Na-K ATPase was incubated in vitro with recombinant Src kinase in the presence or absence of low concentrations of ouabain, and Na-K ATPase phosphorylation and activity was measured.
The results showed that rat 1 Na-K ATPase was phosphorylated only in the presence of Src, as demonstrated by two independent methodologies: 32Pi incorporation (Fig. 8A, left) and Western blotting with an anti-phosphotyrosine antibody (Fig. 8, A, right and B, lane 4 versus lanes 1 and 2). After stripping and reprobing, it was confirmed that the phosphorylated band was immunopositive for 1 Na-K ATPase (not shown). The presence of 10-8-10-10 M ouabain caused, respectively, a statistically significant 28 and 22% increase of 1 Na-K ATPase tyrosine phosphorylation as compared with the absence of ouabain (Fig. 8B, lanes 5 and 6 versus lane 4 and C, left) and a parallel 21% (p < 0.05) and 15% increase of Src phosphorylation at Tyr 418 (Fig. 8B, lanes 5 and 6 versus lane 4 and C, right), and not at Tyr529 (not shown). In the absence of Src, ouabain did not induce 1 Na-K ATPase phosphorylation (Fig. 8B, lane 3 versus 2). The pretreatment of Src with its specific inhibitor, PP2, abolished the Src-induced phosphorylation of Na-K ATPase either in the absence or presence of ouabain (Fig. 8B, lanes 7 and 8). When a Src substrate peptide was added to Src, instead of Na-K ATPase, the Tyr418 phosphorylation of Src did not change either in the absence or presence of ouabain (Fig. 8D).
|
These results indicate that, even in vitro, Src kinase causes a tyrosine phosphorylation of purified rat renal 1 Na-K ATPase that is enhanced by low concentrations of ouabain and is associated with the appearance of a high affinity binding site for ouabain.
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONEXPERIMENTAL PROCEDURESRESULTSDISCUSSIONREFERENCES |
|---|
1 Na-K ATPase with high affinity for ouabain is enriched in caveolae and (b) subnanomolar ouabain concentrations appear to favor the interaction between Na-K ATPase and Src and increase the amount of tyrosine-phosphorylated proteins such as Na-K ATPase, Src, and EGFr. Furthermore, all these in vivo and in vitro effects induced by ouabain are reversed by a new compound, PST 2238, developed as a specific ouabain antagonist (19, 20), but not by the Ca2+ antagonist amlodipine that reduces only the pressor effect of ouabain. Admittedly, the present data do not provide any direct support to the existence of the endogenous ouabain (EO) that is crucial for postulating a pathophysiological role of the new ouabain/Na-K ATPase signaling system. However, the clear organ and molecular pathophysiological changes caused by a ouabain infusion in rats, that only doubles its plasma concentration, may support the biological relevance of EO variations for cardiovascular complications in humans (12-16).
Signaling Mechanism of Ouabain and Na-K ATPase within Membrane Caveolae—The original hypothesis that EO may have a pathophysiological role has been often questioned on the basis of the very low circulating concentrations of EO, which should not be enough to produce a biologically relevant interaction with Na-K ATPase. This criticism is even more pointed when the role of EO is investigated in rat models in which the 1 Na-K ATPase isoform displays a low affinity for ouabain (27). In order to reconcile clinical and experimental evidence of the EO pathophysiological role with the biochemical criteria, it has been suggested that the ouabain-EO/Na-K ATPase complex may play a role in signal transduction.
Studies mainly performed on cultured rat cells indicate that ouabain may control cell growth through the activation of two main intracellular pathways: (i) the Ras/ERK1/2 cascade, mediated by Src-induced EGFr transactivation (6); (ii) the Ca2+-activated intracellular signaling that, through slow Ca2+ oscillations and NF-
B nuclear translocation, controls gene expression induction and cell proliferation (8). However, all these data have been obtained by using ouabain concentrations higher than those of the circulating EO, thus weakening the biological relevance of the results. Only recently, one group demonstrated that ouabain is a potent agent in promoting cell growth and activating the ERK1/2 pathway in proximal rat tubular cells at 10-10 M (9). This study also revealed a minor component of the 1 Na-K ATPase with a high affinity for ouabain. Moreover, it has been recently demonstrated that many of the proteins involved in the receptor-effector coupling and signaling activation can be compartmentalized within restricted membrane microdomains, the caveolae (25, 26). Among these proteins, Na-K ATPase, Src, and EGFr have been found in cardiac caveolae (7).
These data confirm the presence of Na-K ATPase together with Src and EGFr signaling molecules in a low density membrane fraction from rat renal kidney with the predicted properties of caveolae. Rat kidneys were chosen since our previous studies indicated that ouabain specifically modulates the expression and activity of renal 1 Na-K ATPase causing hypertension in OS rats, effects normalized by the ouabain antagonist PST 2238 (20). Furthermore, kidney is particularly enriched in caveolin 1, the specific marker of caveolae (29). In caveolae, we demonstrated the presence of a pool of Na-K ATPase composed by 1, 1, and the a splice variant subunit. The localization of the a variant of Na-K ATPase, independently from b, is in line with published data (30) that exclude the existence of mixed complexes of 1/1/a/b in kidney membranes. The different distribution of the a and b variants of Na-K ATPase into caveolae, however, may be related to the difference at the N-terminal residues between the two spliced variants that, as proposed (30), might affect Na-K ATPase membrane targeting, basolateral signaling, and extracellular matrix interactions.
We show here that infusion of subnanomolar concentrations of ouabain in rats, which causes hypertension and organ hypertrophy, is associated with an increased amount of Na-K ATPase subunits and signaling molecules, including EGFr, Src, and Tyr418-phosphorylated Src, within renal caveolae. This is compatible with the notion that ouabain triggers a Src-EGFr-dependent signaling cascade that culminates in the activation of ERK. Although these data support the original hypothesis that ouabain may confer a signaling transduction function to Na-K ATPase, even at nanomolar concentrations, the question remains as to how subnanomolar concentrations of ouabain might interact with the high ouabain-resistant rat renal 1 Na-K ATPase. Several independent observations suggest that ouabain can indeed interact with rat 1 Na-K ATPase with high affinity. 1) Ouabain concentration-dependent inhibition of the Na-K ATPase activity and 2) Scatchard plot analysis of the [3H]ouabain binding demonstrated that rat renal caveolae, besides the predominant low affinity component, contain a less prominent component with a high ouabain affinity. 3) Co-immunoprecipitation experiments in rat renal caveolae further reinforce the evidence that ouabain, at concentrations as low as 10-9-10-10 M, interacts with the 1 Na-K ATPase causing an increase in Na-K ATPase/Src complex formation. 4) Src-dependent Na-K ATPase phosphorylation on isolated rat 1 Na-K ATPase is selectively enhanced in the presence of 10-10-10-8 M ouabain. Because the presence of the high ouabain affinity 2 and 3 isoforms appears to be excluded, the surprising, but necessary conclusion must be that the high affinity component is associated with the 1 isoform in rat caveolae. Support to this conclusion comes from two other studies performed on rat renal cells (9) and isolated rat nephrons (31), which display a bimodal ouabain dose-response curve, suggestive of the presence of both a high and a low affinity component of Na-K ATPase. It is important to note that although these studies provide data qualitatively similar to those reported here, quantitative differences between the Ki values for the high affinity ouabain binding site can be observed between the former (9, 31) and the present data. In particular, Dmitrieva et al. (9) reported a high affinity Ki around 0.8 nM by measuring the Na-K pump activity in cultured rat proximal tubular cells as ouabain-dependent 86Rb uptake, while Ferraille et al. (31) found a high affinity IC50 of 4.6 µM when measuring the ouabain-dependent Na-K ATPase inhibition curve in isolated rat PCT by a [32P]ATP hydrolysis method. The different tissues examined and the different experimental procedures adopted for measuring the ouabain-dependent Na-K ATPase affinity cannot allow any quantitative comparison among these data. Moreover, in the present study both the low and the high affinity IC50 values of ouabain for the Na-K ATPase may be underestimated because of the presence of 10 mM KCl in the medium for the ATPase activity measurement (28).
At present the cause of the high affinity ouabain effects on rat 1 Na-K ATPase in renal caveolae is unknown and should be investigated. Several factors might be involved. First, the high content of cholesterol and sphingolipids of caveolae (26) might influence either the activity or the affinity of ouabain for the rat 1 Na-K ATPase pool localized within this membrane district (32, 33). The contribution of caveolin 1 to the formation of a high affinity Src/Na-K ATPase complex can also be postulated. Second, the selective presence of the a, but not b, Na-K ATPase subunit, together with the 1 and 1 Na-K ATPase in rat renal caveolae, may participate in the modulation of ouabain affinity in this subdomain. Third, a phosphorylation state of 1 Na-K ATPase within caveolae might induce a conformational modification of the enzyme favoring its interaction with ouabain. In this respect, here we demonstrate that, even in vitro, partially purified rat renal 1 Na-K ATPase is phosphorylated on tyrosine by recombinant Src. This effect is enhanced by 10-10-10-8 M ouabain and is associated with the appearance of a high affinity ouabain binding site, undetectable in the absence of Src. By contrast, ouabain does not affect the phosphorylation of another Src substrate. The result seems consistent with the hypothesis that the process of phosphorylation of Na-K ATPase induced by non-receptor tyrosine kinases, such as Src and Lyn (34), or in general by protein kinases (35), may be of physiological relevance in the regulation of Na-K ATPase function. Finally, the ouabain/Na-K ATPase interaction might also be favored by the process of concentration of ouabain into the kidney that produces tissue concentrations higher than those found in plasma, as shown in the present study and by others (36).
The specificity of the ouabain-induced effects in vivo and in vitro is further provided by the selective antagonism operated by PST 2238. Treatment of OS rats with PST 2238 prevents the ouabain-induced organ hypertrophy and antagonizes the binding of ouabain to the high affinity site of Na-K ATPase in rat renal caveolae, without affecting the low affinity component. Accordingly, in the immunoprecipitation experiments, PST 2238 reduces the formation of the Na-K ATPase/Src complex and the tyrosine phosphorylation of the co-immunoprecipitated proteins. Furthermore, the demonstration that the Ca2+ antagonist amlodipine prevents the ouabain-induced increase of blood pressure without affecting in vivo organ hypertrophy and in vitro ouabain effects further reinforces the specificity of ouabain hypertrophic signaling.
Conclusions—The present study provides evidence that subnanomolar concentrations of ouabain, close to those of the circulating EO in humans, activate a Src kinase-dependent signaling pathway correlated with organ hypertrophy in vivo. This appears to work via an interaction with a high-affinity component of 1 Na-K ATPase localized within caveolae. Although a high-affinity ouabain binding component on a rat 1 1 Na-K ATPase is a surprising finding, evidence for this phenomenon has been obtained in several different types of experiment. These data thus fill the gap between in vitro experiments and cell culture findings and in vivo studies. They support the hypothesis of the pathological role of EO in human hypertension and related cardiovascular complications and provide one possible physiological mechanism. These findings are also relevant to the treatment of human hypertension and related cardiovascular complications since the antihypertensive compound, PST 2238, which is able to antagonize the pressor effect of ouabain, is also effective in preventing the ouabain hypertrophic effect by interfering, at the molecular level, with its dependent signaling pathway.
|
FOOTNOTES |
|---|
To whom correspondence should be addressed: Prassis sigma-tau Research Institute, Via Forlanini, 20019 Settimo Milanese, 20019 Milano, Italy. Tel.: 39-02-3357911; Fax: 39-02-33500408; E-mail: mara.ferrandi{at}prassis.it.
1 The abbreviations used are: EGFr, epidermal growth factor receptor; ERK, extracellular signal-regulated kinase; CHAPS, 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonic acid; CS, control normotensive rats; EO, endogenous ouabain; HR, heart rate; LVFW, left ventricle free-wall; MT, total renal membranes; OS, ouabain-infused rats; SBP, systolic blood pressure; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine.
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONEXPERIMENTAL PROCEDURESRESULTSDISCUSSIONREFERENCES |
|---|
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Zeidan, S. Javadov, S. Chakrabarti, and M. Karmazyn Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ROCK-dependent p38 MAPK translocation to nuclei Cardiovasc Res, January 1, 2008; 77(1): 64 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
 </ |
